What HCPs think about COVID-19’s impact on cancer
pharmaphorum
DECEMBER 9, 2020
Patients with diagnosed COVID-19 on active anti-cancer treatment, follow standard clinical management plans for delay or modification of cancer treatment in a patient with active infection’ [link]. Across both open and closed online networks HCPs are concerned about the future of patient care.
Let's personalize your content